Skip to main content
Figure 1 | Critical Care

Figure 1

From: Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial

Figure 1

Time course of plasma concentrations of presepsin and procalcitonin during ICU stay by survival status. Plasma concentrations of presepsin and procalcitonin 1, 2 and 7 days after enrollment in decedents (n = 50, black) and survivors (n = 50, gray) at ICU discharge. Data are shown as median and interquartile range. Two-way ANOVA for repeated measurements was done on log-transformed biomarker concentrations. **P < 0.005, *P = 0.01 by Mann–Whitney U test.

Back to article page